This site is intended for healthcare professionals only
LoginRegister
OverviewClinical StudiesAuthored by Reviewed by References
Amdepin 2.5

Marketed by:
Cadila Pharmaceuticals
Manufactured By :
Cadila Pharmaceuticals
Medicine Type :
Allopathy
Prescription Type :
Prescription Required
Approval :
DCGI (Drugs Controller General of India)
Pharmacological Class :
Calcium channel blocker,
Therapy Class:
Antihypertensive,
Schedule :
Schedule H
  • https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf
  • https://www.uptodate.com/contents/amlodipine-drug-information
  • https://go.drugbank.com/drugs/DB00381
  • https://www.drugs.com/amlodipine.html
  • https://medlineplus.gov/druginfo/meds/a692044.html
  • https://reference.medscape.com/drug/katerzia-norvasc-amlodipine-342372
  • https://www.rxlist.com/consumer_amlodipine_norvasc/drugs-condition.html
undefined
Dr. Binil Benny
Binil Benny is a doctor of Pharmacy graduate and is currently working as a content writer at Medical Dialogues. He has in-depth knowledge of pharmacology and oncotherapeutics. He can be contacted at editorial@medicaldialogues.in.
undefined
Dr JUHI SINGLA
Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Page Created On:   22 Nov 2022 9:33 AM GMT
Page Last Updated On:   2023-04-01 06:16:39.0
X
sidekick